{
    "2020-11-12": [
        [
            {
                "time": "",
                "original_text": "药明康德(603259)2020年三季报点评：Q3业绩加速增长 长期发展可期",
                "features": {
                    "keywords": [
                        "药明康德",
                        "三季报",
                        "Q3业绩",
                        "加速增长",
                        "长期发展"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "晨会聚焦201112重点关注计算机、纺织服装、银行、香港交易所、申洲国际",
                "features": {
                    "keywords": [
                        "晨会聚焦",
                        "计算机",
                        "纺织服装",
                        "银行",
                        "香港交易所",
                        "申洲国际"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "计算机",
                        "纺织服装",
                        "银行",
                        "港股"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业11月月报暨三季报总结：三季报医药整体表现良好 当前时点重点关注Q3业绩超预期的疫苗、CXO、医疗服务、零售药店等板块",
                "features": {
                    "keywords": [
                        "医药生物",
                        "三季报",
                        "疫苗",
                        "CXO",
                        "医疗服务",
                        "零售药店",
                        "Q3业绩",
                        "超预期"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "疫苗",
                        "CXO",
                        "医疗服务",
                        "零售药店"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-11-12",
                "original_text": "券商首次关注1股并给予买入评级（11月12日）",
                "features": {
                    "keywords": [
                        "券商",
                        "首次关注",
                        "买入评级"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}